Published in Biochem Biophys Res Commun on February 25, 2005
On the origin of order in the genome organization of ssRNA viruses. Biophys J (2011) 0.78
Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications. Sci Rep (2015) 0.78
Maximization of loading and stability of ssDNA:iron oxide nanoparticle complexes formed through electrostatic interaction. Langmuir (2010) 0.76
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles. J Nanobiotechnology (2015) 0.76
Yield Optimisation of Hepatitis B Virus Core Particles in E. coli Expression System for Drug Delivery Applications. Sci Rep (2017) 0.75
Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo. Biomaterials (2016) 0.75
Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell (2008) 2.38
A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev (2005) 2.21
Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A (2002) 1.91
Cytokine induction by the hepatitis B virus capsid in macrophages is facilitated by membrane heparan sulfate and involves TLR2. J Immunol (2005) 1.84
NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A (2002) 1.80
20S proteasomes and protein degradation "by default". Bioessays (2006) 1.63
Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology (2003) 1.59
20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol Cell (2005) 1.37
The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol. Biochemistry (2006) 1.30
Operational definition of intrinsically unstructured protein sequences based on susceptibility to the 20S proteasome. Proteins (2008) 1.20
Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem (2002) 1.19
The nanny model for IDPs. Nat Chem Biol (2009) 1.18
The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1. Cancer Res (2008) 1.16
PGC-1alpha controls hepatitis B virus through nutritional signals. Proc Natl Acad Sci U S A (2006) 1.16
p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle (2005) 1.14
HBXAP, a novel PHD-finger protein, possesses transcription repression activity. Genomics (2002) 1.13
Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A (2005) 1.13
P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1. Proc Natl Acad Sci U S A (2003) 1.06
BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation. J Cell Sci (2011) 1.04
A mutually inhibitory feedback loop between the 20S proteasome and its regulator, NQO1. Mol Cell (2012) 1.03
c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association. J Biol Chem (2003) 1.02
Susceptibility of p53 unstructured N terminus to 20 S proteasomal degradation programs the stress response. J Biol Chem (2009) 0.97
Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles. J Biol Chem (2006) 0.97
Enhancer I predominance in hepatitis B virus gene expression. Mol Cell Biol (2004) 0.95
Autorepression of rfx1 gene expression: functional conservation from yeast to humans in response to DNA replication arrest. Mol Cell Biol (2005) 0.92
Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1alpha. FEBS Lett (2010) 0.92
The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1. Mol Cell Biol (2013) 0.92
E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J Biol Chem (2011) 0.91
RNA interference for antiviral therapy. J Gene Med (2006) 0.90
A regulatory circuit controlling Itch-mediated p73 degradation by Runx. J Biol Chem (2008) 0.90
The "metabolovirus" model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med Hypotheses (2008) 0.88
Hepatocyte metabolic signalling pathways and regulation of hepatitis B virus expression. Liver Int (2011) 0.88
Direct interaction of NRSF with TBP: chromatin reorganization and core promoter repression for neuron-specific gene transcription. Nucleic Acids Res (2004) 0.87
p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1. Methods Enzymol (2004) 0.87
Mechanisms of protein degradation: an odyssey with ODC. Cell Cycle (2005) 0.86
c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol Cell Biol (2010) 0.86
The earliest steps in hepatitis B virus infection. Biochim Biophys Acta (2003) 0.86
Hepatitis B virus activates deoxynucleotide synthesis in nondividing hepatocytes by targeting the R2 gene. Hepatology (2010) 0.84
Context-dependent resistance to proteolysis of intrinsically disordered proteins. Protein Sci (2011) 0.84
The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. Biochem Biophys Res Commun (2009) 0.83
A long HBV transcript encoding pX is inefficiently exported from the nucleus. Virology (2003) 0.82
Thermo-resistant intrinsically disordered proteins are efficient 20S proteasome substrates. Mol Biosyst (2011) 0.82
Interaction of hepatitis B virus with cells. Rev Med Virol (2003) 0.79
p73 overexpression and nuclear accumulation in hepatitis C virus-associated hepatocellular carcinoma. Dig Dis Sci (2002) 0.79
NADH binds and stabilizes the 26S proteasomes independent of ATP. J Biol Chem (2014) 0.79
RNA interference--small RNAs effectively fight viral hepatitis. Liver Int (2004) 0.77
The Hippo tumor suppressor pathway: a brainstorming workshop. Sci Signal (2009) 0.77
Ubiquitin-independent degradation: lessons from the p53 model. Isr Med Assoc J (2006) 0.77
The "Trojan horse" model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector. Biochem Biophys Res Commun (2009) 0.77
Determination of IUP based on susceptibility for degradation by default. Methods Mol Biol (2012) 0.76
The role of p53 in nutrients levels. Cell Cycle (2010) 0.75